Filing Details
- Accession Number:
- 0001099219-21-000180
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-12 13:00:00
- Reporting Period:
- 2021-05-11
- Accepted Time:
- 2021-05-12 16:58:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1099219 | Metlife Inc | MET | Life Insurance (6311) | 134075851 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1770295 | Marlene Debel | Metlife, Inc. 200 Park Avenue New York NY 10166 | Evp & Chief Risk Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-05-11 | 11,000 | $64.58 | 43,112 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices of $64.58 to $64.5902, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
